Valeant's New CEO on the Same Track

When a deeply troubled company replaces its chief executive, it makes sense to expect the new C.E.O. to bring a fresh take to its operations. A clean sweep, so to speak.

But if shareholders in Valeant Pharmaceuticals International envisage a vastly different approach by Joseph C. Papa, the company’s incoming chief executive, they may be disappointed.

Read Full Article »


Comment
Show comments Hide Comments


Related Articles

Market Overview
Search Stock Quotes